ReviewThe Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology2025
A bibliometric analysis and mapping of global research trends in antihypertensive medication adherence (1975-2024).
Review in The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHypertension, a significant risk factor for cardiovascular diseases, has increased dramatically over the decades. It can be mitigated with proper medication utilization and lifestyle modifications. Adherence to antihypertensive medication plays a significant role in reducing severe complications and improving the overall quality of life of people living with hypertension. This study was conducted to assess the global research output and trends in antihypertensive medication adherence.
methodsThe study utilized the Scopus database for bibliometric analysis. The keywords related to antihypertensive medication adherence were searched from the database's inception to 21st December 2024. The retrieved data were analysed using VOSviewer, Biblioshiny and QGIS 3.30.1. The bibliometric maps and indicators were presented based on publication and funding source, most contributed countries and authors, keyword co-occurrence, and other relevant and important indicators.
resultsIn total, 3497 documents specifically related to antihypertensive medication adherence were utilized and they were identified from 1975 to 2024. The publication's annual growth rate was identified as 8.65%. The USA (1144, 33%), the UK (269, 8%), and Germany (246, 7%) are the leading contributors to antihypertensives adherence research. Schmieder R.E was found to be the top published author in this domain. The Journal of Hypertension was identified as the most published source, while National Institute of Health (NIH) revealed as the top funding body supporting antihypertensives adherence research.
conclusionsResearch on antihypertensive medication adherence was largely contributed by developed countries, especially dominated by the USA in most of the indicators. As the contribution from developing countries is limited, LMICs must be prioritized with collaborative research and capacity building to strengthen this adherence research. These efforts gradually help countries to generate context-specific evidence to improve adherence to antihypertensive medications thereby reducing the global burden of hypertension.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.